Results 31 to 40 of about 560,406 (374)

Advanced Glycation End Products’ Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

open access: yesGenetics Research, 2023
Background. Advanced glycation end products’ receptor (AGER) is a multiligand receptor that interacts with a wide range of ligands. Previous studies have shown that abnormal AGER expression is closely related to immune infiltration and tumorigenesis ...
Jun Yang   +10 more
doaj   +1 more source

Training in Radiation and Clinical Oncology in Europe

open access: yesJournal of Medical Education and Curricular Development, 2023
The European population is strongly affected by cancer. Radiotherapy is roughly used in 50% of cancer patients in European countries. The increased cancer burden demands a new generation of radiation/clinical oncologist (RO/CO) that, besides a strong ...
Pedro C Lara   +2 more
doaj   +1 more source

Toxicity of Phase I Radiation Oncology Trials: Worldwide Experience [PDF]

open access: yes, 2010
Introduction: Informed consent involves understanding the risks and benefits of trial enrollment. This is challenging in the phase I setting since true quantitative information is never known.
Den, R. B.   +3 more
core   +2 more sources

Detecting 6 MV X-rays using an organic photovoltaic device [PDF]

open access: yes, 2009
An organic photovoltaic (OPV) device has been used in conjunction with a flexible inorganic phosphor to produce a radiation tolerant, efficient and linear detector for 6 MV Xrays.
Harris, L.   +4 more
core   +1 more source

Does HCC Etiology Impact the Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma? An Asian Liver Radiation Therapy Group Study

open access: yesJournal of Hepatocellular Carcinoma, 2022
Nalee Kim,1,* Jason Chia-Hsien Cheng,2,* Nitin Ohri,3 Wen-Yen Huang,4 Tomoki Kimura,5 Zhao Chong Zeng,6 Victor Ho Fun Lee,7 Chul Seung Kay,8 Jinsil Seong9 1Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan School of Medicine,
Kim N   +8 more
doaj  

Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy

open access: yesBMC Urology, 2017
Background Our aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT).
Daniel N. Cagney   +9 more
doaj   +1 more source

Machine learning applications in radiation oncology

open access: yesPhysics and Imaging in Radiation Oncology, 2021
Machine learning technology has a growing impact on radiation oncology with an increasing presence in research and industry. The prevalence of diverse data including 3D imaging and the 3D radiation dose delivery presents potential for future automation ...
Matthew Field   +4 more
doaj  

Prospects for Radiopharmaceuticals as Effective and Safe Therapeutics in Oncology and Challenges of Tumor Resistance to Radiotherapy

open access: yesDose-Response, 2021
The rapid advances in nuclear medicine have resulted in significant advantages for the field of oncology. The focus is on the application of radiopharmaceuticals as therapeuticals.
Ekaterina Nikolova   +3 more
doaj   +1 more source

Demystifying radiation oncology clinical trial concerns for protocol scientific review and institutional review board committee members

open access: yesContemporary Clinical Trials Communications, 2022
Clinical trials are essential for evaluating advanced technologies and treatment approaches involving radiation therapy to improve outcomes for cancer patients.
Jamiluddin Qazi   +6 more
doaj  

Clinical Characteristics of Radiation Oncology in Korea during Past 10 Years [PDF]

open access: yes, 2009
To understand trends in the clinical characteristics of radiation oncology over the last 10 yr in Korea, annual survey questionnaires were sent to all of Korean radiation oncology facilities since 1990.
Chul Koo Cho   +17 more
core   +2 more sources

Home - About - Disclaimer - Privacy